Former AXA Framlington Biotechnology fund manager Andy Smith has joined biopharma specialist Mann Bioinvest to launch an income-focused fund in the coming weeks.
Odey Asset Management is drafting plans for a UCITS version of Crispin Odey's flagship European hedge fund strategy as part of a wider expansion of its range, Investment Week understands.
Barclays has teamed up with Amundi Investment Solutions to launch a fund providing exposure to US takeovers.
ML Capital Asset Management has released its quarterly report on the alternatives sector, revealing a spike in interest in global emerging markets and Latin America, as well as a doubling of demand for European long/short products.
Commerzbank is set to unveil a commodities-focused investment vehicle as part of the bank's drive into the UK investment market.
Apple's glory days are numbered and it will be impossible for the technology giant to sustain its meteoric pace of growth, according to Ben Rogoff, manager of the £412m Polar Capital Technology trust.
The popularity of risk-rated funds has surged as RDR approaches and investors search for greater certainty in tough markets, but research has revealed vehicles sitting within the same risk grade can perform very differently.
Matrix Group is closing both its UCITS platform and its Asia sub-fund later this year.
The European Commission is consulting on potential changes to the UCITS framework with improvements to the regulation of money market funds, short-termism and harmonising the investment industry's approach to fund redemptions among the items on the agenda....